November 19, 2012
Many of us who live with HIV are alive today in part because we received effective treatment to clear our hepatitis C (HCV) co-infections. Interferon-boosted Ribavirin was a lifesaver, but the interferon side effects could be rugged.
MedPage Today reports that a triple-drug regimen without interferon has been found in a small study to be highly effective in clearing even treatment-resistant HCV genotype 1. FDA approval for clinical use is still a long way off, but we look forward to a future of effective HCV treatment without interferon.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|The Company You Keep: Do Social Networks Influence HIV Status?|
|Incidence of All Cancers but Lung Cancer Drops After HIV Group Stops Smoking|
|New HIV Infections Drop 18% in 6 Years|
|HIV Vaccine Induces Sustained HIV Remission in Proof-of-Concept Study|
|Mental Health Complications of HIV Insufficiently Studied|
|HIV-Associated Neurocognitive Disorders and the Gut Microbiome|